SMYD3 and cancer: Notably, since dysfunctional SMYD3 undoubtedly resulted in abnormal expression of H4K20me3 across genome, the expression of some genes that alleviate aggressive phenotypes could be silenced accordingly in cancer cells, which is probably an additional mechanism involved in the cancer-promoting functions of SMYD3.